David T. Portman serves as Executive at PACIFICHEALTH LABORATORIES INC, where they oversee executive responsibilities. Since joining the company, David T. Portman has executed 2 insider transactions totaling $95.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jan 5, 2007 involved purchasing 100,000 shares valued at $95.0K.
David T. Portman currently holds 405,452 shares of PACIFICHEALTH LABORATORIES INC (PHLI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David T. Portman has been a net buyer of PHLI stock. They have purchased $95.0K and sold $0 worth of shares.
David T. Portman's most recent insider trade was on Jan 5, 2007, when they purchased 100,000 shares at $0.95 per share.
Get notified when new Form 4 filings are submitted
| $0.31 |
| Discretionary |